S Bongrani

533 total citations
48 papers, 440 citations indexed

About

S Bongrani is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, S Bongrani has authored 48 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 13 papers in Molecular Biology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in S Bongrani's work include Asthma and respiratory diseases (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). S Bongrani is often cited by papers focused on Asthma and respiratory diseases (8 papers), Neuroscience and Neuropharmacology Research (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). S Bongrani collaborates with scholars based in Italy, France and Switzerland. S Bongrani's co-authors include Roberta Razzetti, P Schiantarelli, Giancarlo Folco, Maurizio Civelli, Paola Caruso, Alberto Rícci, Elena Bronzetti, Yong-Chun Zeng, O Visioli and M. A. C. M. Bergamaschi and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

S Bongrani

46 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Bongrani Italy 13 143 118 109 81 63 48 440
D.A. Peterson United States 13 146 1.0× 104 0.9× 133 1.2× 46 0.6× 41 0.7× 33 532
Go Kito Japan 15 101 0.7× 134 1.1× 195 1.8× 101 1.2× 54 0.9× 51 798
Kozo Yao Japan 14 127 0.9× 172 1.5× 172 1.6× 34 0.4× 37 0.6× 27 598
Sakae Murata United States 12 141 1.0× 187 1.6× 145 1.3× 29 0.4× 45 0.7× 45 433
M. KAJIWARA Japan 10 120 0.8× 101 0.9× 195 1.8× 25 0.3× 51 0.8× 19 437
Fuminori Masugi Japan 13 129 0.9× 110 0.9× 214 2.0× 44 0.5× 44 0.7× 38 540
Atsuhiro Mizuno Japan 12 64 0.4× 63 0.5× 136 1.2× 38 0.5× 67 1.1× 30 599
A.B. Ebeigbe Nigeria 14 229 1.6× 112 0.9× 114 1.0× 32 0.4× 36 0.6× 51 483
S. Kazda Germany 14 147 1.0× 297 2.5× 193 1.8× 39 0.5× 71 1.1× 23 536
N. N. Share Canada 14 162 1.1× 65 0.6× 139 1.3× 68 0.8× 115 1.8× 33 541

Countries citing papers authored by S Bongrani

Since Specialization
Citations

This map shows the geographic impact of S Bongrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Bongrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Bongrani more than expected).

Fields of papers citing papers by S Bongrani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Bongrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Bongrani. The network helps show where S Bongrani may publish in the future.

Co-authorship network of co-authors of S Bongrani

This figure shows the co-authorship network connecting the top 25 collaborators of S Bongrani. A scholar is included among the top collaborators of S Bongrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Bongrani. S Bongrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rossoni, Giuseppe, Barbara Manfredi, Roberta Razzetti, et al.. (2005). Positive interaction of the β2‐agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea‐pigs. British Journal of Pharmacology. 144(3). 422–429. 12 indexed citations
2.
Pasini, Evasio, et al.. (2003). Effect of nolomirole on monocrotaline-induced heart failure. Pharmacological Research. 49(1). 1–5. 9 indexed citations
3.
Rossoni, Giuseppe, Barbara Manfredi, Viviana Cavalca, et al.. (2003). The Aminotetraline Derivative (±)-(R,S)-5,6-Dihydroxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene Hydrochloride (CHF-1024) Displays Cardioprotection in Postischemic Ventricular Dysfunction of the Rat Heart. Journal of Pharmacology and Experimental Therapeutics. 307(2). 633–639. 7 indexed citations
4.
Masson, Serge, Stefano Chimenti, Monica Salio, et al.. (2001). CHF-1024, A DA2/α2 Agonist, Blunts Norepinephrine Excretion and Cardiac Fibrosis in Pressure Overload. Cardiovascular Drugs and Therapy. 15(2). 131–138. 16 indexed citations
5.
Bergamaschi, M. A. C. M., et al.. (2000). Receptor Profile of a Potent and Selective DA2/α2 Agonist. European Journal of Heart Failure. 2(S1). 95–95. 4 indexed citations
6.
Razzetti, Roberta, et al.. (2000). Haemodynamic and Neurohormones Release Inhibiting Effects of a DA2/α2 Agonist. European Journal of Heart Failure. 2(S1). 94–94. 5 indexed citations
7.
8.
Latini, Roberto, Serge Masson, Fabio Fiordaliso, et al.. (1998). Comparative Efficacy of a DA2/α2 Agonist and a β-Blocker in Reducing Adrenergic Drive and Cardiac Fibrosis in an Experimental Model of Left Ventricular Dysfunction After Coronary Artery Occlusion. Journal of Cardiovascular Pharmacology. 31(4). 601–608. 25 indexed citations
9.
10.
Civelli, Maurizio, Paola Caruso, Roberta Razzetti, et al.. (1996). The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363. British Journal of Pharmacology. 118(4). 923–928. 27 indexed citations
11.
Caruso, Paola, et al.. (1996). Inhibition of parathyroid hormone-stimulated resorption in cultured fetal rat long bones by the main metabolites of ipriflavone. Calcified Tissue International. 58(6). 419–422. 9 indexed citations
12.
Ghezzo, C., Roberto Civitelli, Sandrine Cadel, et al.. (1996). Ipriflavone does not alter bone apatite crystal structure in adult male rats. Calcified Tissue International. 59(6). 496–499. 9 indexed citations
13.
Zeng, Yong-Chun, et al.. (1995). Effect of long-term treatment with L-deprenyl on the age-dependent microanatomical changes in the rat hippocampus. Mechanisms of Ageing and Development. 79(2-3). 169–185. 21 indexed citations
14.
15.
Amenta, Francesco, et al.. (1994). Neuroanatomy of Aging Brain. Annals of the New York Academy of Sciences. 717(1). 33–44. 12 indexed citations
16.
Amenta, Francesco, et al.. (1994). Influence of treatment with l-deprenyl on the structure of the cerebellar cortex of aged rats. Mechanisms of Ageing and Development. 75(2). 157–167. 9 indexed citations
17.
18.
Folco, Giancarlo, Roberta Fruttero, R. CALVINO, et al.. (1993). No-Mimetic Furoxans: Arylsulphonylfuroxans and Related Compounds. Pharmacological Research. 28(3). 203–212. 15 indexed citations
19.
Civelli, Maurizio, T. Viganò, Daniela Acerbi, et al.. (1991). Modulation of arachidonic acid metabolism by orally administered morniflumate in man. Inflammation Research. 33(3-4). 233–239. 12 indexed citations
20.
Berti, F., Fulvio Magni, Giuseppe Rossoni, S Bongrani, & P Schiantarelli. (1990). Pharmacological activity of bamifylline on lung anaphylaxis: studies. Pharmacological Research. 22(2). 143–150. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D.A. Peterson Breakdown of academic impact, for papers by Go Kito Breakdown of academic impact, for papers by Kozo Yao Breakdown of academic impact, for papers by Sakae Murata Breakdown of academic impact, for papers by M. KAJIWARA Breakdown of academic impact, for papers by Fuminori Masugi Breakdown of academic impact, for papers by Atsuhiro Mizuno Breakdown of academic impact, for papers by A.B. Ebeigbe Breakdown of academic impact, for papers by S. Kazda Breakdown of academic impact, for papers by N. N. Share
Rankless by CCL
2026